Gannet BioChem's Commitment to Sustainability and Climate Action
Gannet BioChem, a prominent specialty chemical Contract Development and Manufacturing Organization (CDMO), has recently taken a significant step towards sustainability by having its near-term greenhouse gas (GHG) emissions reduction targets validated by the Science Based Targets initiative (SBTi). This validation emphasizes the company's steadfast dedication to environmentally responsible growth and positions it as a pioneer in the industry.
Setting Ambitious Emissions Targets
As part of SBTi's rigorous validation process, Gannet BioChem has established robust targets that include:
Reduction of GHG Emissions
Notably, the company aims to reduce its absolute Scope 1 and 2 GHG emissions by an impressive 63% by 2035, using 2020 as its baseline year. This ambitious goal reflects the organization's commitment to responsible and sustainable operations.
Measuring Scope 3 Emissions
In addition to addressing its direct emissions, Gannet BioChem is also focusing on measuring and reducing Scope 3 emissions, which encompass those produced indirectly in the supply chain. This comprehensive approach highlights the company’s understanding of its broader environmental impact.
Leadership Insights
“Our work touches every stage of activated polymer and bioconjugation innovation, from supporting discovery programs to enabling commercial manufacturing,” remarked Nicholas Shackley, CEO of Gannet BioChem. He emphasized the company’s responsibility towards both therapeutic advancements and environmental stewardship. Having SBTi validate their targets is not just a feather in their cap; it is a driving force that encourages the team to keep innovating for a sustainable future.
Developing a Sustainable Framework
Over recent years, Gannet BioChem has been diligently crafting a science-led sustainability framework that prioritizes transparency and continuous development. Current initiatives include:
Enhancing Energy Efficiency
The company is committed to increasing energy efficiency across its operational sites. This includes evaluating renewable energy alternatives to decrease reliance on fossil fuels.
Managing Scope 3 Emissions
Strengthening processes for measuring and managing Scope 3 emissions is another critical aspect of their sustainability strategy. By enhancing data collection and analysis, Gannet aims to reduce its overall environmental impact.
Building Partnerships
Establishing partnerships that focus on responsible sourcing and low-impact logistics is essential for Gannet BioChem. These collaborations are integral to supporting their sustainability roadmap and ensuring that all aspects of their supply chain are aligned with these goals.
About Gannet BioChem
With over three decades of experience, Gannet BioChem specializes in developing and manufacturing polyethylene glycol (PEG) reagents, key components in advanced biopharmaceutical and therapeutic products. Operating from a state-of-the-art 124,000-square-foot FDA-inspected facility, the company is equipped to provide end-to-end GMP production, supporting both clinical and commercial therapeutics. Their dedicated team strives to deliver reliable and innovative solutions, adapting to the evolving needs of the global biopharmaceutical industry.
About Ampersand Capital Partners
Ampersand Capital Partners, a middle-market private equity firm established in 1988, manages around $3 billion in assets, focusing on growth-oriented investments in healthcare. With locations in Boston, Amsterdam, and London, Ampersand combines private equity with operational expertise to foster significant market-leading advancements in their portfolio companies.
Frequently Asked Questions
What is Gannet BioChem’s main objective regarding sustainability?
Gannet BioChem aims to significantly reduce its GHG emissions and enhance its environmental responsibility through validated targets set by the SBTi.
How much does Gannet BioChem plan to reduce its emissions?
The company plans to cut its Scope 1 and 2 GHG emissions by 63% by 2035 from a 2020 baseline.
What are Scope 3 emissions, and why is Gannet BioChem focusing on them?
Scope 3 emissions are those produced indirectly, especially in the value chain. Gannet BioChem is focusing on these to comprehensively understand and minimize their environmental impact.
What significance does SBTi validation hold for the company?
SBTi validation serves as recognition of Gannet BioChem's commitment to meaningful climate action, motivating them to further innovate and enhance sustainability efforts.
How does Gannet BioChem ensure its product quality?
The company operates from a state-of-the-art facility and employs a highly experienced team to maintain strict adherence to GMP standards, ensuring high-quality production.
